Pyrimidinones as casein kinase II (CK2) modulators
A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ARLYN ARCALAS JOERG BUSSENIUS JEAN-CLAIRE LIMUN MANALO CHARLES M. BLAZEY WAI KI VICKY CHAN NEEL KUMAR ANAND PATRICK KEARNEY PEIWEN ZHOU TSZE H. TSANG SERGEY EPSHTEYN CSABA J. PETO ABIGAIL R. KENNEDY HONGWANG DU MOHAMED ABDULKADER IBRAHIM MOON HWAN KIM AMY LEW TSUHAKO KENNETH D. RICE |
| description | A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2006304874A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2006304874A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2006304874A13</originalsourceid><addsrcrecordid>eNrjZDAKqCzKzM1MyczLz0stVkgsVkhOLE7NzFPIzswDMhQ8PRU0nL2NNBVy81NKcxJL8ouKeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGBmbGBiYW5iaOhMXGqAAK1K8Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrimidinones as casein kinase II (CK2) modulators</title><source>esp@cenet</source><creator>ARLYN ARCALAS ; JOERG BUSSENIUS ; JEAN-CLAIRE LIMUN MANALO ; CHARLES M. BLAZEY ; WAI KI VICKY CHAN ; NEEL KUMAR ANAND ; PATRICK KEARNEY ; PEIWEN ZHOU ; TSZE H. TSANG ; SERGEY EPSHTEYN ; CSABA J. PETO ; ABIGAIL R. KENNEDY ; HONGWANG DU ; MOHAMED ABDULKADER IBRAHIM ; MOON HWAN KIM ; AMY LEW TSUHAKO ; KENNETH D. RICE</creator><creatorcontrib>ARLYN ARCALAS ; JOERG BUSSENIUS ; JEAN-CLAIRE LIMUN MANALO ; CHARLES M. BLAZEY ; WAI KI VICKY CHAN ; NEEL KUMAR ANAND ; PATRICK KEARNEY ; PEIWEN ZHOU ; TSZE H. TSANG ; SERGEY EPSHTEYN ; CSABA J. PETO ; ABIGAIL R. KENNEDY ; HONGWANG DU ; MOHAMED ABDULKADER IBRAHIM ; MOON HWAN KIM ; AMY LEW TSUHAKO ; KENNETH D. RICE</creatorcontrib><description>A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=AU&NR=2006304874A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=AU&NR=2006304874A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ARLYN ARCALAS</creatorcontrib><creatorcontrib>JOERG BUSSENIUS</creatorcontrib><creatorcontrib>JEAN-CLAIRE LIMUN MANALO</creatorcontrib><creatorcontrib>CHARLES M. BLAZEY</creatorcontrib><creatorcontrib>WAI KI VICKY CHAN</creatorcontrib><creatorcontrib>NEEL KUMAR ANAND</creatorcontrib><creatorcontrib>PATRICK KEARNEY</creatorcontrib><creatorcontrib>PEIWEN ZHOU</creatorcontrib><creatorcontrib>TSZE H. TSANG</creatorcontrib><creatorcontrib>SERGEY EPSHTEYN</creatorcontrib><creatorcontrib>CSABA J. PETO</creatorcontrib><creatorcontrib>ABIGAIL R. KENNEDY</creatorcontrib><creatorcontrib>HONGWANG DU</creatorcontrib><creatorcontrib>MOHAMED ABDULKADER IBRAHIM</creatorcontrib><creatorcontrib>MOON HWAN KIM</creatorcontrib><creatorcontrib>AMY LEW TSUHAKO</creatorcontrib><creatorcontrib>KENNETH D. RICE</creatorcontrib><title>Pyrimidinones as casein kinase II (CK2) modulators</title><description>A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKqCzKzM1MyczLz0stVkgsVkhOLE7NzFPIzswDMhQ8PRU0nL2NNBVy81NKcxJL8ouKeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGBmbGBiYW5iaOhMXGqAAK1K8Y</recordid><startdate>20070426</startdate><enddate>20070426</enddate><creator>ARLYN ARCALAS</creator><creator>JOERG BUSSENIUS</creator><creator>JEAN-CLAIRE LIMUN MANALO</creator><creator>CHARLES M. BLAZEY</creator><creator>WAI KI VICKY CHAN</creator><creator>NEEL KUMAR ANAND</creator><creator>PATRICK KEARNEY</creator><creator>PEIWEN ZHOU</creator><creator>TSZE H. TSANG</creator><creator>SERGEY EPSHTEYN</creator><creator>CSABA J. PETO</creator><creator>ABIGAIL R. KENNEDY</creator><creator>HONGWANG DU</creator><creator>MOHAMED ABDULKADER IBRAHIM</creator><creator>MOON HWAN KIM</creator><creator>AMY LEW TSUHAKO</creator><creator>KENNETH D. RICE</creator><scope>EVB</scope></search><sort><creationdate>20070426</creationdate><title>Pyrimidinones as casein kinase II (CK2) modulators</title><author>ARLYN ARCALAS ; JOERG BUSSENIUS ; JEAN-CLAIRE LIMUN MANALO ; CHARLES M. BLAZEY ; WAI KI VICKY CHAN ; NEEL KUMAR ANAND ; PATRICK KEARNEY ; PEIWEN ZHOU ; TSZE H. TSANG ; SERGEY EPSHTEYN ; CSABA J. PETO ; ABIGAIL R. KENNEDY ; HONGWANG DU ; MOHAMED ABDULKADER IBRAHIM ; MOON HWAN KIM ; AMY LEW TSUHAKO ; KENNETH D. RICE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2006304874A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ARLYN ARCALAS</creatorcontrib><creatorcontrib>JOERG BUSSENIUS</creatorcontrib><creatorcontrib>JEAN-CLAIRE LIMUN MANALO</creatorcontrib><creatorcontrib>CHARLES M. BLAZEY</creatorcontrib><creatorcontrib>WAI KI VICKY CHAN</creatorcontrib><creatorcontrib>NEEL KUMAR ANAND</creatorcontrib><creatorcontrib>PATRICK KEARNEY</creatorcontrib><creatorcontrib>PEIWEN ZHOU</creatorcontrib><creatorcontrib>TSZE H. TSANG</creatorcontrib><creatorcontrib>SERGEY EPSHTEYN</creatorcontrib><creatorcontrib>CSABA J. PETO</creatorcontrib><creatorcontrib>ABIGAIL R. KENNEDY</creatorcontrib><creatorcontrib>HONGWANG DU</creatorcontrib><creatorcontrib>MOHAMED ABDULKADER IBRAHIM</creatorcontrib><creatorcontrib>MOON HWAN KIM</creatorcontrib><creatorcontrib>AMY LEW TSUHAKO</creatorcontrib><creatorcontrib>KENNETH D. RICE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ARLYN ARCALAS</au><au>JOERG BUSSENIUS</au><au>JEAN-CLAIRE LIMUN MANALO</au><au>CHARLES M. BLAZEY</au><au>WAI KI VICKY CHAN</au><au>NEEL KUMAR ANAND</au><au>PATRICK KEARNEY</au><au>PEIWEN ZHOU</au><au>TSZE H. TSANG</au><au>SERGEY EPSHTEYN</au><au>CSABA J. PETO</au><au>ABIGAIL R. KENNEDY</au><au>HONGWANG DU</au><au>MOHAMED ABDULKADER IBRAHIM</au><au>MOON HWAN KIM</au><au>AMY LEW TSUHAKO</au><au>KENNETH D. RICE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrimidinones as casein kinase II (CK2) modulators</title><date>2007-04-26</date><risdate>2007</risdate><abstract>A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2006304874A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pyrimidinones as casein kinase II (CK2) modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T02%3A39%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ARLYN%20ARCALAS&rft.date=2007-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2006304874A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |